Form EFFECT Unicycive Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 15, 2026 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rebuilders International Announces Amazon Best Seller Recognition for 10 Week Divorce Recovery, a Data Driven Roadmap Built from Thousands of Real Recovery Stories
- Robinhood Announces Pricing of Private Offering of $2.0 Billion of Convertible Senior Notes Due 2029
- Quarterman Realty Group Inc. Announces Expanded Real Estate Education Support for South Jersey Buyers, Sellers, and Relocating Families
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
